These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23354395)

  • 21. Myocardial metabolism before and after valve replacement for aortic stenosis.
    Vanky FB; Hakanson E; Szabó Z; Jorfeldt L; Svedjeholm R
    J Cardiovasc Surg (Torino); 2006 Jun; 47(3):305-13. PubMed ID: 16760867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose Transporters in Cardiac Metabolism and Hypertrophy.
    Shao D; Tian R
    Compr Physiol; 2015 Dec; 6(1):331-51. PubMed ID: 26756635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal Models of Dysregulated Cardiac Metabolism.
    Bugger H; Byrne NJ; Abel ED
    Circ Res; 2022 Jun; 130(12):1965-1993. PubMed ID: 35679363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanism of amino acid loading in improving postischemic myocardial recovery.
    Bolling SF; Childs KF; Ning XH
    J Surg Res; 1995 Jul; 59(1):174-8. PubMed ID: 7630124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.
    Kolwicz SC; Purohit S; Tian R
    Circ Res; 2013 Aug; 113(5):603-16. PubMed ID: 23948585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty acid oxidation in the reperfused ischemic heart.
    Kantor PF; Dyck JR; Lopaschuk GD
    Am J Med Sci; 1999 Jul; 318(1):3-14. PubMed ID: 10408755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion.
    Carvajal K; Zarrinpashneh E; Szarszoi O; Joubert F; Athea Y; Mateo P; Gillet B; Vaulont S; Viollet B; Bigard X; Bertrand L; Ventura-Clapier R; Hoerter JA
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3136-47. PubMed ID: 17337600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial metabolism is better preserved after blood cardioplegia in infants.
    Amark K; Berggren H; Björk K; Ekroth A; Ekroth R; Nilsson K; Sunnegårdh J
    Ann Thorac Surg; 2006 Jul; 82(1):172-8. PubMed ID: 16798209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrate metabolism as a determinant for postischemic functional recovery of the heart.
    Taegtmeyer H; Goodwin GW; Doenst T; Frazier OH
    Am J Cardiol; 1997 Aug; 80(3A):3A-10A. PubMed ID: 9293950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.
    Obrzut S; Tiongson J; Jamshidi N; Phan HM; Hoh C; Birgersdotter-Green U
    J Cardiovasc Transl Res; 2010 Dec; 3(6):643-51. PubMed ID: 20842468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application.
    Mallet RT; Olivencia-Yurvati AH; Bünger R
    Exp Biol Med (Maywood); 2018 Jan; 243(2):198-210. PubMed ID: 29154687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catecholamine-induced myocardial hypoxia in the presence of impaired coronary dilatability independent of external cardiac work.
    RAAB W; VAN LITH P; LEPESCHKIN E; HERRLICH HC
    Am J Cardiol; 1962 Mar; 9():455-70. PubMed ID: 14489543
    [No Abstract]   [Full Text] [Related]  

  • 33. Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism.
    Lopaschuk GD
    Am J Cardiol; 1998 Sep; 82(5A):14K-17K. PubMed ID: 9737481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic model of myocardial energy metabolism under normal and ischemic conditions.
    Salem JE; Saidel GM; Stanley WC; Cabrera ME
    Ann Biomed Eng; 2002 Feb; 30(2):202-16. PubMed ID: 11962772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction.
    Wang W; Zhang F; Xia Y; Zhao S; Yan W; Wang H; Lee Y; Li C; Zhang L; Lian K; Gao E; Cheng H; Tao L
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1160-H1169. PubMed ID: 27542406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effects of triiodothyronine on glucose and fatty acid metabolism during reperfusion of ischemic rat hearts.
    Liu Q; Clanachan AS; Lopaschuk GD
    Am J Physiol; 1998 Sep; 275(3):E392-9. PubMed ID: 9725804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial metabolic effects of methylprednisolone sodium succinate in acute myocardial ischemia.
    Masters TN; Harbold NB; Hall DG; Jackson RD; Mullen DC; Daugherty HK; Robicsek F
    Am J Cardiol; 1976 Mar; 37(4):557-63. PubMed ID: 1258793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free fatty acid metabolism during myocardial ischemia and reperfusion.
    Hendrickson SC; St Louis JD; Lowe JE; Abdel-aleem S
    Mol Cell Biochem; 1997 Jan; 166(1-2):85-94. PubMed ID: 9046024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of high arterial oxygen tension on function, blood flow distribution, and metabolism in ischemic myocardium.
    Cason BA; Wisneski JA; Neese RA; Stanley WC; Hickey RF; Shnier CB; Gertz EW
    Circulation; 1992 Feb; 85(2):828-38. PubMed ID: 1735173
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.